Latest Announcements

Medi Assist Healthcare Services Limited has appointed Gaurav Bhatnagar as its Chief TPA Officer, bringing 18 years of experience in commercial operations, value creation, and scaling businesses.

Prism Johnson Ltd has announced that India Ratings & Research Private Limited has upgraded its ratings/outlook for the existing Non-convertible Debentures and bank loan facilities of the Company from 'IND A+/Positive' to 'IND AA-/Positive'.

Crompton Greaves Consumer Electricals Limited has announced its Q1 FY27 results, with consolidated revenue growth of 11.8% YoY, EBITDA growth of 14.2%, and PAT growth of 15.2% YoY. The company reported double-digit growth across segments, driven by pricing interventions, operating leverage, and cost initiatives.

Wakefit Innovations Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations increasing by 16.6% YoY to INR 4,049.1 mn, and reported EBITDA (excluding Other Income) rising to INR 564.0 mn with an EBITDA margin of 13.9%. Profit before Tax increased to INR 363.1 mn, an increase of 85.1% YoY, while Profit After Tax for the quarter stood at INR 233.8 mn, registering a YoY increase of 19.2%. The company has also added 27 new stores during the quarter, taking the total active COCO stores to 165.

Prism Johnson Limited has informed the Exchange about Credit Rating- Revision, with India Ratings upgrading its ratings/outlook for the existing Non-convertible Debentures and bank loan facilities of the Company from 'IND A+/Positive' to 'IND AA-/Positive'.

Crompton Greaves Consumer Electricals Ltd. reported its standalone & consolidated financials for the quarter ended 30th June 2026, with consolidated revenue growth of 11.8% YoY, EBITDA growth of 14.2%, and PAT growth of 15.2% YoY.

Wakefit Innovations Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations increasing by 16.6% YoY to INR 4,049.1 million, and reported EBITDA (excluding Other Income) increasing to INR 564.0 million, with an EBITDA margin of 13.9%. Profit Before Tax rose to INR 363.1 million, an increase of 85.1% YoY, while Profit After Tax for the quarter stood at INR 233.8 million, registering a YoY increase of 19.2%. The company has also added 27 new stores during the quarter, taking the total active COCO stores to 165.

KSB Ltd has announced the construction of an additional shed at its Shirwal plant, which will increase the plant's capacity by 20% by 2027, with an investment of INR 400 million, financed through internal accruals.

BLS E-Services Limited has informed the Exchange about Investor Presentation with respect to Un-audited financial results of the Company for the first quarter ended June 30, 2026.

GlaxoSmithKline Pharmaceuticals Ltd announced its Q1 FY 2027 earnings call, with Managing Director Mr. Bhushan Akshikar and Chief Financial Officer Mr. Rononjit Biswas presenting the results. The company reported a 13.5% industry growth, with a balanced mix of volume, price, and new introductions. GlaxoSmithKline's portfolio showed a significant presence in therapy areas such as anti-infectives, pain, respiratory, nutritional supplements, vitamins, dermatologicals, and hormones and vaccines, which all grew double-digit. The company's growth was balanced across geographies, including metros, Tier 1 cities, Tier 2 and rural markets, and among specialists, super specialists, and general practitioners.

KSB Limited has informed the Exchange about capacity addition through the construction of a new shed at the Shirwal plant, with a proposed capacity addition of 20% and an expected completion date of 2027. The investment required is INR 400 million, to be financed through internal accruals.

BLS E-Services Limited has announced its unaudited financial results for the first quarter ended June 30, 2026, with a 23.3% YoY growth in total income and a 7.9% YoY increase in EBITDA. The company has also completed the 100% acquisition of Atyati Technologies, a leading AI-powered banking technology company.

Valiant Organics Ltd has announced that CRISIL Ratings Limited has reaffirmed the credit ratings assigned to the company's bank facilities, with a revised outlook from 'Negative' to 'Stable'. The long-term rating remains at Crisil A-/ Stable, while the short-term rating is Crisil A2+.

BLS E-Services Ltd reported a strong Q1FY27 with 23.3% YoY growth in total income and 7.9% YoY growth in EBITDA. The company also announced the successful completion of the 100% acquisition of Atyati Technologies.

Kokuyo Camlin Limited has submitted unaudited financial results for the quarter ended 30th June, 2026, with revenue from operations at ₹1811.26 crores, total income at ₹2927.39 crores, and profit before tax at ₹983.40 crores.

Fortis Healthcare Limited has announced its unaudited consolidated financial results for the quarter ended June 30, 2026, with consolidated revenues at INR 2,545 Cr, up 17.5%, and operating EBITDA margin at 22.3%. The company's hospital business revenues grew 19.0% and operating EBITDA margin was 21.5%. The company has also announced its entry into a new market in Odisha and plans to expand its presence in key clusters.

Valiant Organics Ltd has received a reaffirmation of its credit ratings from CRISIL Ratings Limited, with a revised outlook from 'Negative' to 'Stable'. The company's long-term rating has been reaffirmed at 'Crisil A-', while the short-term rating remains 'Crisil A2+'.

Fortis Healthcare Ltd announced its unaudited consolidated financial results for the quarter ended June 30, 2026, with consolidated revenues at INR 2,545 Cr, up 17.5%, and operating EBITDA margin at 22.3%. The company also announced its entry into an Operations and Management agreement for a 300-bedded greenfield multi-specialty hospital in Cuttack, Odisha.

GEE Ltd has announced unaudited financial results for the quarter ended June 30, 2026, with a net profit of Rs. 684.55 lakhs and earnings per share of Rs. 1.32. The company has sold two immovable properties during the quarter, resulting in a profit of Rs. 369.55 lakhs, which has been disclosed as an exceptional item.

Gulshan Polyols Limited has released an investor presentation for Q1 FY27, highlighting a strong start to the year with improved operational efficiencies, disciplined procurement, and higher asset utilization. The company expects to achieve its FY27 guidance, driven by the ethanol business, which continues to be the primary growth engine.